Nicotine Replacement Therapy Patch

DRUG4 trials

Sponsors

Pfizer, University of Vermont, University of Virginia

Conditions

E-Cig UseNicotine AddictionQuitting SmokingSmoking CessationTobacco Use Cessation

Phase 2

Quit Smoking Study for People Who Use E-Cigarettes

CompletedNCT04946825

University of VermontE-Cig Use, Nicotine Addiction, Quitting Smoking

Start: 2021-06-27End: 2023-10-25Updated: 2025-05-22

Phase 4

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders

CompletedNCT01456936

PfizerSmoking Cessation

Start: 2011-11-30End: 2015-01-31Updated: 2016-06-10

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.

CompletedNCT01574703

PfizerSmoking Cessation

Start: 2012-05-31End: 2015-07-31Updated: 2016-12-29

Unknown Phase

Feasibility of Delivering VergeRx at FQHCs

Active, not recruitingNCT06161675

University of VirginiaTobacco Use Cessation

Start: 2024-09-23End: 2026-07-01Target: 100Updated: 2025-10-30

Related Papers

Do tobacco regulatory and economic factors influence smoking cessation outcomes? A post-hoc analysis of the multinational EAGLES randomised controlled trial

BMJ Open2024-09-011 citations

Medication-assisted quit rates in participants with smoking-relateddiseases in EAGLES: Post hoc analyses of a double-blind,randomized, placebo-controlled clinical trial

Tobacco Induced Diseases2022-05-1011 citations

The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial

Depression and Anxiety2022-05-0124 citations

Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial

Mayo Clinic Proceedings2021-06-0816 citations

Psychiatric Comorbidity and Multimorbidity in the EAGLES Trial: Descriptive Correlates and Associations With Neuropsychiatric Adverse Events, Treatment Adherence, and Smoking Cessation

Nicotine & Tobacco Research2021-03-3113 citations

Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation

JAMA Network Open2021-01-1937 citations

Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.

2019-06-0316 citations

Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.

2019-03-0714 citations

Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers

JAMA Internal Medicine2018-04-09147 citations

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

2016-04-22617 citations